Kolexia
Gisselbrecht Christian Oncologie médicale
Gisselbrecht Christian
Oncologie médicale
Hôpital Saint-Louis
Paris, France
184 Activités
0 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Lymphomes Lymphome B Lymphome B diffus à grandes cellules Lymphome T Lymphome T périphérique Maladie de Hodgkin Lymphome malin non hodgkinien Leucémies Récidive tumorale locale

Collaborateurs

Voir plus
Mounier Nicolas
Mounier Nicolas
Hôpital De l'Archet, Nice, France
Briere-Berthet Josette
Briere-Berthet Josette
Hôpital Saint-Louis, Paris, France
Tilly Herve
Tilly Herve
Centre Henri-Becquerel, Rouen, France
Thieblemont Catherine
Thieblemont Catherine
Hôpital Saint-Louis, Paris, France

Industries

Voir plus
Roche
3 collaboration(s)
Dernière en 2021
Health Advances
2 collaboration(s)
Dernière en 2020
MSD
1 collaboration(s)
Dernière en 2022
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

Voir plus
Chemotherapy Before Autologous Stem Cell Transplantation +/- Rituximab in Relapsed or Refractory Aggressive Non-Hodgkin's Lymphoma: Phase III Study Of Gemcitabine, Dexamethasone, And Cisplatin Compared To Dexamethasone, Cytarabine, And Cisplatin Plus/Minus Rituximab [(R)-GDP vs (R)-DHAP] As Salvage Chemotherapy For Patients With Relapsed Or Refractory Aggressive Histology Non-Hodgkin's Lymphoma Prior To Autologous Stem Cell Transplant And Followed By Maintenance Rituximab vs Observation
Essai Clinique (NCIC Clinical Trials Group)   03 août 2023
Comparison of overall survival of lisocabtagene maraleucel (liso-cel) versus standard of care (SOC) adjusting for crossover in second-line (2L) R/R large B-cell lymphoma
17th International Conference on Malignant Lymphoma, Palazzo dei Congressi, Lugano, Switzerland, 13 ‐ 17 June, 2023   09 juin 2023
The current status of autologous transplantation in PTCL
Youtube @ VJHemOnc – Video Journal of Hematological Oncology   10 mai 2023
Promising advances in the field of PTCL: druggable mutations, brentuximab vedotin & L-asparaginase
Youtube @ VJHemOnc – Video Journal of Hematological Oncology   10 mai 2023
Outcome of Patients with Primary Mediastinal Large B-Cell Lymphoma after R-CHOP21, R-CHOP14 and R-ACVBP: A Pooled Analysis of Clinical Trials from Lysa
Annual Meeting Abstracts 2022   15 novembre 2022
Do we have to exclude all relapsed diffuse large B-cell lymphoma patients not in complete remission from autologous stem cell transplant?
British journal of haematology   19 septembre 2022
Reaching beyond maximum grade: progress and future directions for modernising the assessment and reporting of adverse events in haematological malignancies.
The Lancet. Haematology   02 mai 2022
A randomized phase 3 trial of autologous vs allogeneic transplantation as part of first-line therapy in poor-risk peripheral T-NHL.
Blood   06 décembre 2021
The European Medicines Agency Review of Tafasitamab in Combination With Lenalidomide for the Treatment of Adult Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma.
HemaSphere   18 novembre 2021
Comparison of 2-year outcomes with CAR T cells (ZUMA-1) vs salvage chemotherapy in refractory large B-cell lymphoma.
Blood advances   01 novembre 2021